Medtronic

Medtronic, a US-based company in the Medical, precision and optical instruments, watches and clocks industry, reported its carbon emissions for 2025 at approximately 5,518,000,000 kg CO2e. This includes Scope 1 emissions of 174,000,000 kg CO2e, Scope 2 emissions of 79,000,000 kg CO2e, and Scope 3 emissions of 5,265,000,000 kg CO2e. For 2024, only Scope 3 emissions were reported, totalling 866,000,000 kg CO2e. In 2023, Medtronic's Scope 1 emissions were 131,500,000 kg CO2e and Scope 2 emissions were 125,200,000 kg CO2e. Looking back to 2020, the company reported Scope 1 emissions of 156,000,000 kg CO2e and Scope 2 emissions of 233,000,000 kg CO2e.

Medtronic is committed to reducing its environmental impact with several climate initiatives. The company aims to be carbon neutral in its operations by fiscal year 2030, with an ambitious target to reduce greenhouse gas emissions by 50% by fiscal year 2025. This commitment covers all scopes of emissions.

Medtronic PLC has near-term Science Based Targets initiative (SBTi) commitments to reduce absolute Scope 1 and Scope 2 greenhouse gas emissions by 52% by fiscal year 2030, using a fiscal year 2020 base year. Additionally, Medtronic PLC pledges to increase its active annual sourcing of renewable electricity from 1.29% in fiscal year 2020 to 100% by fiscal year 2030. The company also aims for 75% of its suppliers, by emissions covering purchased goods and services and capital goods, to have science-based targets by fiscal year 2030. Furthermore, Medtronic PLC commits to reduce absolute Scope 3 GHG emissions from upstream transportation and distribution, business travel, and end-of-life treatment of sold products by 37.5% by fiscal year 2034 from a fiscal year 2024 base year. Medtronic PLC also has a long-term net-zero commitment by 2050, as recognised by the SBTi.